Causes of Death in Anticoagulated Patients With Atrial Fibrillation

Abstract Background Oral anticoagulation reduces the risk of mortality in atrial fibrillation (AF), but examination of the causes of death is essential to design new strategies to further reduce the high mortality rates observed in this population. Objectives The authors sought to analyze and compar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2016-12, Vol.68 (23), p.2508-2521
Hauptverfasser:	Gómez-Outes, Antonio, MD, PhD, Lagunar-Ruíz, Julián, MD, Terleira-Fernández, Ana-Isabel, MD, PhD, Calvo-Rojas, Gonzalo, MD, PhD, Suárez-Gea, Maria Luisa, PharmD, PhD, Vargas-Castrillón, Emilio, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anticoagulants Anticoagulants - therapeutic use apixaban atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Atrial Fibrillation - mortality Cardiac arrhythmia Cardiology Cardiovascular Cause of Death - trends Clinical trials dabigatran Embolisms Female Follow-Up Studies Humans Internal Medicine Male Meta-analysis Mortality Patients Quality Registries Retrospective Studies rivaroxaban Software Stroke Stroke - etiology Stroke - mortality Stroke - prevention & control Studies Survival Rate - trends United States - epidemiology warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!